GENEVA, Feb. 2 -- FUSION PHARMACEUTICALS INC. (270 Longwood Road SouthHamilton, Ontario L8P 0A6) filed a patent application (PCT/CA2024/050996) for "PSMA-TARGETED RADIOPHARMACEUTICALS FOR TREATMENT OF CANCER" on Jul 26, 2024. With publication no. WO/2025/019952, the details related to the patent application was published on Jan 30, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ROLAND, Kevin (3061 Preserve DriveOakville, Ontario L6M 0W6), DUFFY, Ian Ruixiang (268 Ellen Davidson DriveOakville, Ontario L6M 0V2), BHALLA, Rajiv (229 Grosvenor Avenue NorthHamilton, Ontario L8L 7T1)
Abstract:
...